There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
SPICe briefings
Date published:
29 June 2018
The Regulation and Governance of Medical Devices in Scotland - The procurement and adoption of medical devices
Medical devices are more difficult to manage than medicines in terms of procurement as there are many more devices on the market that medicines.
Committee reports
Date published:
1 February 2018
Technology and innovation in health and social care - Annexe A - Minutes of meeting
Technology and Innovation in Health and Social Care: The Committee took evidence, in a round table format, from—
Professor Brian McKinstry, Professor of Primary Care eHealth, University of Edinburgh;
Dr Juliet Spiller, Consultant in Palliative Medicine, Scottish Partnership for Palliative Care;
Rami Okasha, Executive Director of Strategy and Improvement, Care Inspectorate;
Stephen Whiston, Head of Strategic Planning and Performance, Argyll & Bute Health and Social Care Partnership;
Dr David Chung, Vice President, Royal College of Emergency Medicine Scotland;
Aileen Bryson, Practice and Policy Lead, Royal Pharmaceutical Society Scotland;
Chaloner Chute, Chief Technology Officer, The Digital Health and Care Institute; and
Maureen Falconer, Regional Manager Scotland, Information Commissioner's Office
4.
Questions and Answers
Date answered:
16 January 2025
S6W-32915
Community Pharmacy Scotland also receive a copy of the Medicines Supply Alert Notices for onward dissemination across their network.
Questions and Answers
Date answered:
20 September 2022
S6W-10450
To ask the Scottish Government, in light of reports that the Department of Health and Social Care has asked NICE to conduct an appraisal of remdesivir, tocilizumab, casirivimab and imdevimab, baricitinib, sotrovimab, molnupiravir, nirmatrelvir and ritonavir, and tixagevimab and cilgavimab for treating people with coronavirus disease 2019 (COVID-19) in the NHS in England, whether it will refer any of these currently available COVID-19 treatments to the Scottish Medicines...
Committee reports
Date published:
27 April 2017
EU engagement and scrutiny of the Committees of the Scottish Parliament 2016-17 - Response from the Health and Sport Committee
The directive is due to be implemented into UK law by February 2018.
New medicines and clinical trials
EU regulation provides a harmonising approach to medicine recognition across member states.
Last updated:
14 March 2025
BB20250317
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Last updated:
7 March 2023
BB20200608
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Committee reports
Date published:
30 June 2020
Supply and demand for medicines - Other forms of support as part of reviews
Other forms of support as part of reviews
Adam Stachura, Head of Policy and Communications, Age Scotland,iHealth and Sport Committee, Official Report, 18 February 2020, Col 11 spoke of how reviews should not just be about medicines but should encompass other forms of care which may represent savings and better clinical outcomes for patients using the examp...
Questions and Answers
Date answered:
5 October 2022
S6W-11099
It is worth noting that the decision to prescribe any medicine for an individual, and which medicine to prescribe, is entirely one for the clinician in charge of the individual’s care to make, having taken into account their clinical condition.
Official Report
Meeting date:
15 March 2022
Health, Social Care and Sport Committee 15 March 2022
It found that 95 per cent of people support pharmacists advising on medicines; 87 per cent think that it is important that pharmacists prescribe medicines; 89 per cent think that pharmacists should be the first port of call for common clinical conditions; and 81 per cent think that pharmacists should monitor, review and adjust medicines for long-term conditions.
